Janowsky A - Search Results

1

Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters.

Torralva R, Eshleman AJ, Swanson TL, Schmachtenberg JL, Schutzer WE, Bloom SH, Wolfrum KM, Reed JF, Janowsky A. Torralva R, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 2020 Sep;374(3):376-391. doi: 10.1124/jpet.120.265561. Epub 2020 Jun 8. J Pharmacol Exp Ther. 2020. PMID: 32513839 Free PMC article.

2

Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.

Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK. Janowsky A, et al. J Pharmacol Exp Ther. 1992 Jun;261(3):1282-90. J Pharmacol Exp Ther. 1992. PMID: 1534844

3

Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.

Neve KA, Henningsen RA, Kinzie JM, De Paulis T, Schmidt DE, Kessler RM, Janowsky A. Neve KA, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1990 Mar;252(3):1108-16. J Pharmacol Exp Ther. 1990. PMID: 2138666

4

Characterization of a recombinant human dopamine transporter in multiple cell lines.

Eshleman AJ, Neve RL, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1995 Jul;274(1):276-83. J Pharmacol Exp Ther. 1995. PMID: 7616409

5

Release of dopamine via the human transporter.

Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. Mol Pharmacol. 1994 Feb;45(2):312-6. Mol Pharmacol. 1994. PMID: 7906856

6

Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters.

Eshleman AJ, Stewart E, Evenson AK, Mason JN, Blakely RD, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Neurochem. 1997 Oct;69(4):1459-66. doi: 10.1046/j.1471-4159.1997.69041459.x. J Neurochem. 1997. PMID: 9326274 Free article.

7

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A. Johnson RA, et al. Among authors: janowsky a. Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886

8

Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1999 May;289(2):877-85. J Pharmacol Exp Ther. 1999. PMID: 10215666

9

Drug interactions with the dopamine transporter in cryopreserved human caudate.

Eshleman AJ, Wolfrum K, Mash DC, Christensen K, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 2001 Feb;296(2):442-9. J Pharmacol Exp Ther. 2001. PMID: 11160629

10

NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant mice.

Mason JN, Eshleman AJ, Belknap JK, Crabbe JC, Loftis JM, Macey TA, Janowsky A. Mason JN, et al. Among authors: janowsky a. Alcohol Clin Exp Res. 2001 May;25(5):651-60. Alcohol Clin Exp Res. 2001. PMID: 11371713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters